EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:749601 |
| ChEBI Name | ranibizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Applications: | antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. hypoglycemic agent A drug which lowers the blood glucose level. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ranibizumab (CHEBI:749601) has role antiglaucoma drug (CHEBI:39456) |
| ranibizumab (CHEBI:749601) has role antineoplastic agent (CHEBI:35610) |
| ranibizumab (CHEBI:749601) has role hypoglycemic agent (CHEBI:35526) |
| ranibizumab (CHEBI:749601) has role ophthalmology drug (CHEBI:66981) |
| ranibizumab (CHEBI:749601) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| BCD-300 | ChEMBL |
| Byooviz | ChEMBL |
| Cimerli | ChEMBL |
| FAB-12 VARIANT Y0317 | ChEMBL |
| FYB-201 | ChEMBL |
| FYB201 | ChEMBL |
| Brand Names | Source |
|---|---|
| Lucentis | ChEMBL |
| Ranivisio | ChEMBL |
| Rimmyrah | ChEMBL |
| Ximluci | ChEMBL |